Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Trials of human immunodeficiency virus type 1 (HIV) pre- and postexposure prophylaxis show promise. Here, we describe a novel strategy for deciphering mechanisms of prophylaxis failure that could improve therapeutic outcomes. A healthcare worker began antiretroviral prophylaxis immediately after a high-risk needlestick injury but nonetheless became viremic 11 weeks later. Single-genome sequencing of plasma viral RNA identified 15 drug susceptible transmitted/founder HIV genomes responsible for productive infection. Sequences emanating from these genomes exhibited extremely low diversity, suggesting virus sequestration as opposed to low-level replication as the cause of breakthrough infection. Identification of transmitted/founder viruses allows for genome-wide assessment of molecular mechanisms of prophylaxis failure.

Original publication

DOI

10.1093/infdis/jit485

Type

Journal article

Journal

J Infect Dis

Publication Date

15/11/2013

Volume

208

Pages

1598 - 1603

Keywords

HIV-1 transmission, multiple virus transmission, occupational exposure, post-exposure prophylaxis, single genome sequencing, virus sequestration, Anti-HIV Agents, Drug Resistance, Viral, Female, Genome, Viral, HIV Infections, HIV-1, Humans, Middle Aged, Mutation, Phylogeny, Premedication, RNA, Viral, Sequence Analysis, DNA, Treatment Failure